Chemical Profile and Molecular Characteristics
Sarolaner (CAS 1398609-39-6) is a novel isoxazoline-class compound developed as a potent ectoparasiticide. Its molecular structure features a unique trifluoromethyloxadiazolyl moiety connected to a spirocyclic lactam core, which confers exceptional binding affinity to target receptors while maintaining favorable pharmacokinetic properties. The compound exists as a white to off-white crystalline solid with limited water solubility but excellent solubility in organic solvents, characteristics that have been optimized through careful molecular design for enhanced bioavailability and sustained duration of action.
Mechanism of Action and Target Specificity
Sarolaner exerts its parasiticidal effect through highly selective inhibition of invertebrate gamma-aminobutyric acid (GABA)-gated chloride channels and, to a lesser extent, glutamate-gated chloride channels. This mechanism disrupts normal neuromuscular transmission in target parasites, leading to rapid paralysis and death. The compound demonstrates remarkable selectivity for arthropod receptors over mammalian GABA receptors, contributing to its excellent safety profile in dogs and cats. Its high binding affinity and slow dissociation kinetics from target sites enable prolonged activity with single-dose treatments, providing extended protection against reinfestation.
Therapeutic Applications and Clinical Indications
Developed specifically for veterinary use, Sarolaner is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations including Ixodes scapularis, Ixodes ricinus, Amblyomma americanum, and Rhipicephalus sanguineus in dogs. It is also approved for the treatment of sarcoptic mange and ear mite infestations in canine patients. The compound is formulated as chewable tablets for monthly oral administration, with dosing based on animal body weight to ensure consistent efficacy across different breed sizes.
Pharmacokinetic Profile and Distribution Characteristics
After oral administration, Sarolaner is rapidly absorbed and achieves peak plasma concentrations within hours, followed by extensive distribution to target tissues. The compound demonstrates favorable linear pharmacokinetics with dose-proportional exposure and minimal accumulation upon repeated monthly dosing. Its lipophilic nature facilitates distribution to the skin and hair follicles, creating a reservoir effect that provides continuous protection. The mean terminal half-life of approximately 12 days supports sustained efficacy throughout the monthly dosing interval, ensuring consistent parasiticidal activity.
Formulation Development and Manufacturing
We supply Sarolaner active pharmaceutical ingredient that meets stringent veterinary pharmaceutical standards, suitable for development of palatable chewable tablets. The manufacturing process employs advanced synthetic routes with rigorous purification steps to ensure high chemical purity and consistent performance. Our technical data supports formulation optimization, including compatibility studies with common veterinary pharmaceutical excipients and stability assessments under various storage conditions.
Quality Specifications and Analytical Methods
Our Sarolaner API complies with comprehensive quality standards, including identification by infrared spectroscopy and HPLC, assay (97.0-103.0%), and of related substances. We employ validated HPLC methods with UV detection for precise quantification and impurity profiling, along with tests for residual solvents, heavy metals, and microbial limits. Particle size distribution is carefully controlled to ensure consistent dissolution characteristics and bioavailability in finished formulations.
Safety Profile and Adverse Event Management
Clinical studies have demonstrated that Sarolaner is generally well-tolerated in dogs, with the most common adverse reactions being mild and transient gastrointestinal signs such as vomiting and diarrhea. Neurological signs including tremors and ataxia have been reported rarely, primarily in dogs with pre-existing seizure disorders. The compound has shown no evidence of teratogenic, mutagenic, or carcinogenic potential in extensive safety assessments. Appropriate precautions include monitoring for potential drug interactions in animals receiving medications that may lower the seizure threshold.
Stability Profile and Storage Requirements
Sarolaner exhibits excellent chemical stability when stored in well-closed containers protected from light and moisture at controlled room temperature. Long-term stability studies support a shelf life of at least 36 months for the API under recommended storage conditions. The compound maintains stability across the pH range typical of gastrointestinal fluids, ensuring consistent performance following oral administration. Our comprehensive stability data package includes forced degradation studies and supports regulatory submissions in global markets.
Regulatory Status and Global Approvals
Sarolaner has received veterinary drug approvals in multiple countries including the United States (FDA), European Union (EMA), and other major markets. Our API manufacturing process complies with Good Manufacturing Practice requirements for veterinary pharmaceuticals, and we maintain comprehensive regulatory documentation including Type II Drug Master Files. The compound is protected by patent in many jurisdictions, with data exclusivity periods supporting market protection in key regions.
Market Position and Commercial Significance
As a leading compound in the isoxazoline class of parasiticides, Sarolaner occupies an important position in the growing global market for veterinary ectoparasiticides. Its monthly dosing convenience, broad-spectrum activity, and excellent safety profile have established it as a preferred choice among veterinarians and pet owners. Market growth is driven by increasing pet ownership, rising awareness of vector-borne diseases, and growing demand for convenient and effective parasite control solutions. We maintain robust manufacturing capabilities to support the global supply needs for this important veterinary therapeutic.
Q1. Can I get a free sample?
We can send you a samll free sample, and you only need to pay for the shipping cost.
Q2. What is the HyperChem payment term?
T/T in advance
LC at sight
DP at sight
Bank transfer
PayPal
Bitcoin...
Q3. What is HyperChem shipment policy?
Our policy is to strive for the quickest shipment time possible.
For ready stock samples, they are usually shipped within 3 working days after payment received.
For non-ready stock, please contact HyperChem sales team to negotiate.
Q4. What is HyperChem shipment term?
By Express
FedEx UPS DHL EMS
Fast: 3-7 days around, high cost, door to door service
By Air
Suitable for more than 50kg
Fast: 3-7 days, hight cost, port to port, professional broker needed
By Sea
Suitable for more than 500kg
Fast: 7-45 days, low cost, port to port, professional broker needed
We will always attempt to utilize the quickest and most affordable way for customers to receive orders. And follow -up with customers via email for all shipment details as well as updated track information until it arrives without damage.
Q5. What HyperChem will provide after shipment?
For sample orders:
After shipment is done, an timely email including:
1. Track details (Fedex /TNT/DHL/EMS Track number)
2. Packaging photo
3. COA, MSDS, etc
4. Dispatch date & Estimated arriving time
5. Shipping invoice
For commercial orders
A full set of shipment documents as well as package photos can be provided in scan-copy and original, to help customers complete the customs clearance process.
Established in 2013, Hyper Chem has exclusive tie-ups with leading manufacturers, supplying raw materials produced in GMP and ISO 9002 certified facilities, and provides high-quality ingredients and raw materials to cater to the requirements of our diverse range of clients.
Among them, our key client industrial sectors around the global are:
Pharmaceuticals
Nutrition Ingredients/ Dietary supplements
Cosmetic Ingredients
Food Ingredients
Veterinary API
Agriculture fertilizer
Custom Synthesis lab supply
HyperChem provides to its wonderful and honorable clients comprehensive purchasing and distribution services which ensure that we are delivering the right generic, raw, or customized product, make sure that we are delivering it at the right time, ensure that it is delivered in the specified amount, and in the right kind of packaging to clients and customers of all types of industries irrespective of their size of operation.
India
Paraguay
Egypt
Indonesia
